Hans L. M. Beck
Radboud University Nijmegen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hans L. M. Beck.
Experimental Cell Research | 1984
F.C.S. Ramaekers; Hans L. M. Beck; G. Peter Vooijs; Chester J. Herman
Using two human tumour cell lines, T24 bladder carcinoma and Molt-4 leukemia, flow-cytometric DNA analysis of pure and mixed cell populations was performed using cellular cytokeratin content to distinguish cytokeratin-containing carcinoma cells from leukemia cells which do not contain cytokeratin. Using cytokeratin content to gate DNA analysis, the same specificity and sensitivity of cellular DNA content and distribution measurement could be achieved by single-pass FCM analysis of a mixture of the two cell types as was seen when analysing pure populations of the two cell lines. This technique has broad applicability to FCM analysis of mixed populations composed of cells from different tissues of origin.
The Journal of Urology | 1987
Herbert F.M. Karthaus; W.F.J. Feitz; Frans C. S. Ramaekers; Hans L. M. Beck; Ben Th. Hendriks; P. H. K. Jap
Four human renal cell carcinoma xenografts (RC2, RC14, RC43, NC65), maintained in nude mice for several years, were investigated in a multi - disciplinary study, using (immuno) histochemical, biochemical and ultrastructural techniques. Histological, cellular, nuclear and biological characteristics were investigated. All tumors showed histologically recognizable features of human renal cell carcinomas, although marked differences between the four tumors were seen, both at the histological and ultrastructural level. Flowcytometric analysis of tumor cell suspensions allowed DNA quantification as well as the detection of subpopulations. Immunohistochemical staining procedures using tissue specific antibodies against intermediate filament proteins revealed two populations of tumor cells. Most tumor cells in three of the xenografts coexpressed cytokeratins and vimentin, while in RC43 most of the tumor cells expressed only vimentin. Northern blot analysis showed a higher expression of vimentin mRNA in all tumors as compared to normal kidney tissue. RC43 showed a three-fold higher level of vimentin mRNA than the other xenografts. Growth potential in the human tumor cloning system was evaluated by temporal growth pattern analysis. These experiments showed that the xenografts resemble human primary renal cell tumors in different ways, and reflect different characteristics that can be present in human renal cell carcinoma.
Protides of the biological fluids | 1985
F.C.S. Ramaekers; Hans L. M. Beck; Peter S. Oud; G.P. Vooijs; C.J. Herman
Abstract Using a rabbit antiserum to human skin keratins and a monoclonal antibody to cytokeratin 18, we have labeled cultured human urothelial carcinoma cells (T24), normal and neoplastic human endometrial cells, and human bladder tumor cells in suspensions of complex cell mixtures. After propidium iodide staining, the epithelial (tumor) cells can be analyzed separately from non-epithelial cells for their DNA content. This method has, therefore, a broad applicability to flow cytometric (FCM) analysis of human tumors composed of cells from different origins.
Archive | 1987
W.F.J. Feitz; A. J. M. C. Beniers; Hans L. M. Beck; B. Th. Hendriks; W. P. Peelen; F.M.J. Debruyne
Since the first description of the Dunning rat prostate tumor (Dunning 1963) several sublines of this tumor, originating from the dorsal lobe of rat prostatic tissue, have been described (Claflin and McKinney 1977; Isaacs et al. 1978; Isaacs et al. 1981; Smolev et al. 1977). One of these tumor lines, the MATLyLu tumor line which shows metastatic potential to lymph nodes and lung tissue (Isaacs et al. 1981), has been investigated over several years in our laboratory.
Cytometry | 1985
Peter S. Oud; Jos B. J. Henderik; Hans L. M. Beck; José A. M. Veldhuizen; G. Peter Vooijs; Chester J. Herman; F.C.S. Ramaekers
Virchows Archiv | 2009
Mikael Lundin; Janusz Szymas; Ewert Linder; Hans L. M. Beck; Peter C.M. de Wilde; Han van Krieken; Marcial García Rojo; Ignacio Moreno; Aurelio Ariza; Sitki Tuzlali; Sergülen Dervişoğlu; Heikki Helin; Veli-Pekka Lehto; Johan Lundin
Cytometry | 1986
Peter S. Oud; Ton Hanselaar; José A. M. Reubsaet-Veldhuizen; Jos W. R. Meijer; Anita H. Gemmink; Martin M. M. Pahlplatz; Hans L. M. Beck; G. Peter Vooijs
Cytometry | 1986
Peter S. Oud; José A. M. Reubsaet-Veldhuizen; Hans L. M. Beck; Martin M. M. Pahlplatz; Gerard H.F.M. Hesselmans; Huub G. Hermkens; Johan Tas; J. James; G. Peter Vooijs
Cytometry | 1986
Frans C. S. Ramaekers; Hans L. M. Beck; W.F.J. Feitz; Peter Simon Oud; F. M. J. Debruyne
Total Quality Management & Business Excellence | 1985
Wouter F. J. Feitz; Hans L. M. Beck; A. W. G. B. Smeets; F. M. J. Debruyne; Frans C. S. Ramaekers